Latest news
Alteogen signs $365m Hybrozyme licensing deal with pharma company - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 10:36:16 GMTAlteogen Licenses Subcutaneous Platform to Undisclosed Global Pharma Company in Deal Worth Up to $365 Million - BioPharm InternationalBioPharm International · Wed, 05 Aug 2026 19:10:58 GMTAurzen Announces Exclusive E1R Pre-Launch Voucher Program, Offering Early Supporters $30 Off with a $1 Reservation - The Manila TimesThe Manila Times · Wed, 05 Aug 2026 14:31:32 GMTAlteogen Announces Exclusive License Agreement with a Global Pharmaceutical Company for the Development and Commercialization of a Hybrozyme™-Enabled Subcutaneous Biologic Product - Yahoo FinanceYahoo Finance · Wed, 05 Aug 2026 12:00:00 GMTStock Splits Calendar for: - Yahoo! Finance CanadaYahoo! Finance Canada · Wed, 05 Aug 2026 06:52:30 GMT